Tulane University study: Medicaid expansion correlates with earlier diabetes diagnoses
Early detection of diabetes is more frequent in states
that have instituted Medicaid expansion than in states that have not accepted
Medicaid funds, according to a new study in
“Diabetes Care.”
In 2014, 26 states and the District of Columbia expanded
Medicaid following passage of the Affordable Care Act (ACA), while 24 states
did not. The study examines the impact of new healthcare coverage created by
Medicaid expansion on diabetes diagnosis and treatment.
Using records from Quest Diagnostics, which maintains a
large clinical laboratory database, the researchers identified patients ages
19-64 newly diagnosed with diabetes. The researchers found that the number
of Medicaid-enrolled patients with newly diagnosed diabetes increased by 23
percent in the 26 states and District of Columbia that expanded Medicaid while
in the 24 states that did not expand Medicaid, the number of patients increased
by just 0.4 percent.
“It is likely that changes in access to health care for patients with Medicaid contributed to testing for diabetes at an earlier stage of disease,” say the researchers. “We postulate that these Medicaid patients with new identified diabetes will experience better management of their disease than if diagnoses had been made later. This could be anticipated to lead to fewer long-term complications.”
“Further research is needed on this important topic not just in regard to diabetes but also for other chronic diseases like hypertension,” says study member Dr. Vivian Fonseca, Tullis–Tulane Alumni Chair in Diabetes and Professor of Medicine, Tulane University School of Medicine. “In our population there are a lot of disparities in terms of health outcomes. It would be important to see if these disparities related to ethnic groups and socio-economic issues are reduced or eliminated by the ACA-related Medicaid expansion.”
Arthur Nead
Phone: 504-247-1443
anead@tulane.edu
Phone: 504-247-1443
anead@tulane.edu
